CAS: 1661854-97-2
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | TAS6417 REF: IN-DA01EO8VCAS: 1661854-97-2 | 95% | 62.00 €~611.00 € | Tue 10 Dec 24 |
 | TAS6417 REF: TM-T16996CAS: 1661854-97-2 | 99.19% | 96.00 €~3,045.00 € | Mon 16 Dec 24 |
 | TAS 6417 REF: 3D-FT166464CAS: 1661854-97-2 | Min. 95% | To inquire | Tue 21 Jan 25 |
| TAS 6417 hydrochloride REF: 3D-BT171643CAS: 1661854-97-2 | Min. 95% | 271.00 €~1,379.00 € | Mon 03 Feb 25 |
Ref: IN-DA01EO8V
| 1mg | 62.00 € | ||
| 5mg | 66.00 € | ||
| 10mg | 95.00 € | ||
| 25mg | 123.00 € | ||
| 50mg | 153.00 € | ||
| 100mg | 218.00 € | ||
| 250mg | 576.00 € | ||
| 500mg | 611.00 € |
Estimated delivery in United States, on Tuesday 10 Dec 2024
TAS6417
CAS:1661854-97-2
Zipalertinib (TAS6417, CLN-081) is a novel, highly potent, orally active covalent EGFR tyrosine kinase inhibitor.Cost-effective …
Formula:
C23H20N6O
Purity:
99.19%
Color and Shape:
Solid
Molecular weight:
396.44
Ref: TM-T16996
| 1mg | 96.00 € | ||
| 2mg | 122.00 € | ||
| 5mg | 184.00 € | ||
| 10mg | 305.00 € | ||
| 25mg | 616.00 € | ||
| 50mg | 985.00 € | ||
| 100mg | 1,513.00 € | ||
| 500mg | 3,045.00 € | ||
| 1mL*10mM (DMSO) | 214.00 € |
Estimated delivery in United States, on Monday 16 Dec 2024
TAS 6417
CAS:1661854-97-2
Inhibits mutated EGFR with exon 20 insertion; anti-cancer agent
Formula:
C23H20N6O
Purity:
Min. 95%
Molecular weight:
396.44 g/mol
Ref: 3D-FT166464
| 5mg | To inquire | ||
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Tuesday 21 Jan 2025
TAS 6417 hydrochloride
CAS:1661854-97-2
TAS 6417 hydrochloride is a natural compound that has potent antitumor activity. It can induce …
Formula:
C23H20N6O·HCl
Purity:
Min. 95%
Molecular weight:
432.91 g/mol
Ref: 3D-BT171643
| 5mg | 271.00 € | ||
| 10mg | 386.00 € | ||
| 25mg | 678.00 € | ||
| 50mg | 861.00 € | ||
| 100mg | 1,379.00 € |
Estimated delivery in United States, on Monday 3 Feb 2025
